TYRA BIOSCIENCES INC (TYRA:NASDAQ)
$32.56 -0.61 (-1.839%)
Analysed TYRA BIOSCIENCES INC (TYRA:NASDAQ) News Sources
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet.
19-03-2026
fool.com
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
20-03-2026
fool.com
A Look At Tyra Biosciences (TYRA) Valuation After $126 Million Stock Sale And Late Stage Trial Progress
04-04-2026
yahoo.com
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
17-04-2026
yahoo.com
Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib
24-04-2026
yahoo.com
Tyra Biosciences to Participate in Upcoming Investor Conferences
07-05-2026
yahoo.com
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
13-05-2026
yahoo.com
Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Momentum
14-05-2026
yahoo.com
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
17-05-2026
fool.com
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY
21-05-2026
yahoo.com
What is the current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The current price of TYRA BIOSCIENCES INC (TYRA:NASDAQ) is $32.56.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is $-0.61.
TYRA BIOSCIENCES INC (TYRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of TYRA BIOSCIENCES INC (TYRA:NASDAQ) since the previous trading day is -1.839%.
What is the most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent average sentiment score for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ)?
The most recent sentiment for TYRA BIOSCIENCES INC (TYRA:NASDAQ) is .
SEC-8K** Filing Available For TYRA BIOSCIENCES INC (TYRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.